Completed NA INTERVENTIONAL 2-arm NCT04649801

Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplantation (CASTLE-HTx)

Sponsor: Heart and Diabetes Center North-Rhine Westfalia

Conditions Atrial Fibrillation Heart Failure

Interventions Atrial fibrillation ablation

Updated 5 times since 2021 Last updated: May 16, 2023 Started: Dec 1, 2020 Primary completion: Dec 31, 2022 Completion: May 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04649801, this NA trial focuses on Atrial Fibrillation and Heart Failure and remains completed. Sponsored by Heart and Diabetes Center North-Rhine Westfalia, it has been updated 5 times since 2020, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Oct 2021 — Jun 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting NA

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heart and Diabetes Center North-Rhine Westfalia

Data source: Heart and Diabetes Center North-Rhine Westfalia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bad Oeynhausen, Germany